Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Influenza Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global influenza vaccine market exhibited XX growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Influenza vaccines, also known as flu shots, provide protection against various types of influenza viruses. They are available in several options, including inactivated influenza vaccine [IIV], recombinant influenza vaccine [RIV], and live attenuated influenza vaccine (LAIV). Their effectiveness can vary, depending on the patient's age and health status. Presently, governments of numerous countries have mandated immunization against influenza among children between six months and five years of age. This is escalating the need for influenza vaccines to reduce the high risk of developing severe flu complications and hospitalization among infants around the world.

Influenza Vaccine Market Trends:

The rising prevalence of diabetes, cancer, anemia, obesity, immune deficiencies, human immunodeficiency virus (HIV), metabolic diseases, kidney disease, neurological disorder, and chronic heart and lung disorders, such as bronchopulmonary dysplasia, cystic fibrosis, and asthma, is increasing the risk of developing influenza. This acts as a major factor bolstering the market growth. In addition, children under five years of age are usually at a high risk of complications from high fever, convulsions, and pneumonia. This, in confluence with growing concerns among parents about the well-being of their children, is positively influencing the demand for influenza vaccines. Moreover, as immune systems decline with age, the rising geriatric population worldwide is catalyzing the demand for influenza vaccines to prevent serious illness, the need for hospitalization, and the possibility of a heart attack. Several vaccines are also available that help boost immune response in adults over sixty-five years. Besides this, health agencies of numerous countries are introducing free seasonal influenza vaccination programs for people of all age groups, which is creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global influenza vaccine market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on vaccine type, technology, age group and route of administration.

Breakup by Vaccine Type:

  • Quadrivalent
  • Trivalent
     

Breakup by Technology:

  • Egg-based
  • Cell-based
     

Breakup by Age Group:

  • Pediatric
  • Adult
     

Breakup by Route of Administration:

  • Injection
  • Nasal Spray
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AstraZeneca plc, CSL Limited, Daiichi Sankyo Company Limited, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gamma Vaccines Pty Ltd, GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi and SINOVAC.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Vaccine Type, Technology, Age Group, Route of Administration, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, AstraZeneca plc, CSL Limited, Daiichi Sankyo Company Limited, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gamma Vaccines Pty Ltd, GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi and SINOVAC.
Customization Scope 10% Free Customization
Report Price and Purchase Option                                     Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global influenza vaccine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global influenza vaccine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the age group?
  • What is the breakup of the market based on the route of administration?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global influenza vaccine market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Influenza Vaccine Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Vaccine Type
    6.1    Quadrivalent
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Trivalent
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Technology
    7.1    Egg-based
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Cell-based
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Age Group
    8.1    Pediatric
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Adult
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by Route of Administration
    9.1    Injection
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Nasal Spray
        9.2.1 Market Trends
        9.2.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abbott Laboratories
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    AstraZeneca plc
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    CSL Limited
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Daiichi Sankyo Company Limited
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    Emergent BioSolutions Inc.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    F. Hoffmann-La Roche AG
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 SWOT Analysis
        15.3.7    Gamma Vaccines Pty Ltd
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    GlaxoSmithKline plc
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Merck & Co. Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Novartis AG
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Pfizer Inc.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    Sanofi
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis
        15.3.13    SINOVAC
           15.3.13.1 Company Overview
           15.3.13.2 Product Portfolio
           15.3.13.3 Financials

List of Figures

Figure 1: Global: Influenza Vaccine Market: Major Drivers and Challenges
Figure 2: Global: Influenza Vaccine Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Influenza Vaccine Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Influenza Vaccine Market: Breakup by Vaccine Type (in %), 2020
Figure 5: Global: Influenza Vaccine Market: Breakup by Technology (in %), 2020
Figure 6: Global: Influenza Vaccine Market: Breakup by Age Group (in %), 2020
Figure 7: Global: Influenza Vaccine Market: Breakup by Route of Administration (in %), 2020
Figure 8: Global: Influenza Vaccine Market: Breakup by Region (in %), 2020
Figure 9: Global: Influenza Vaccine (Quadrivalent) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Influenza Vaccine (Quadrivalent) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Influenza Vaccine (Trivalent) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Influenza Vaccine (Trivalent) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Influenza Vaccine (Egg-based) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Influenza Vaccine (Egg-based) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Influenza Vaccine (Cell-based) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Influenza Vaccine (Cell-based) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Influenza Vaccine (Pediatric) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Influenza Vaccine (Pediatric) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Influenza Vaccine (Adult) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Influenza Vaccine (Adult) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Influenza Vaccine (Injection) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Influenza Vaccine (Injection) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Influenza Vaccine (Nasal Spray) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Influenza Vaccine (Nasal Spray) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: North America: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: North America: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: United States: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: United States: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Canada: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Canada: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Asia-Pacific: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Asia-Pacific: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: China: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: China: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Japan: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Japan: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: India: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: India: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: South Korea: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: South Korea: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Australia: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Australia: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Indonesia: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Indonesia: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Others: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Others: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Europe: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Europe: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Germany: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Germany: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: France: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: France: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: United Kingdom: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: United Kingdom: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Italy: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Italy: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Spain: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Spain: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Russia: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Russia: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Others: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Others: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Latin America: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Latin America: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Brazil: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Brazil: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Mexico: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Mexico: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Others: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Others: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Middle East and Africa: Influenza Vaccine Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Middle East and Africa: Influenza Vaccine Market: Breakup by Country (in %), 2020
Figure 73: Middle East and Africa: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Global: Influenza Vaccine Industry: SWOT Analysis
Figure 75: Global: Influenza Vaccine Industry: Value Chain Analysis
Figure 76: Global: Influenza Vaccine Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Influenza Vaccine Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Influenza Vaccine Market Forecast: Breakup by Vaccine Type (in Million US$), 2021-2026
Table 3: Global: Influenza Vaccine Market Forecast: Breakup by Technology (in Million US$), 2021-2026
Table 4: Global: Influenza Vaccine Market Forecast: Breakup by Age Group (in Million US$), 2021-2026
Table 5: Global: Influenza Vaccine Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 6: Global: Influenza Vaccine Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Influenza Vaccine Market: Competitive Structure
Table 8: Global: Influenza Vaccine Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links